METTL3 and colorectal carcinoma: Down-regulation of METTL3 would reduce MDSC accumulation through the m6 A-BHLHE 41-CXCL1 /CXCR 2 axis to maintain the activation and proliferation of CD4+ T-cells and CD8+ T-cells, which play an inhibitory role in CRC.